Novel TIE-2 inhibitor BAY-826 displaysin vivoefficacy in experimental syngeneic murine glioma models-Reference-Cited by-同舟云学术

Novel TIE-2 inhibitor BAY-826 displaysin vivoefficacy in experimental syngeneic murine glioma models

Published:2016-12-12 Issue:1 Volume:140 Page:170-182
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Schneider Hannah¹,Szabo Emese¹,Machado Raquel A. C.¹,Broggini-Tenzer Angela²,Walter Alexander³,Lobell Mario⁴,Heldmann Dieter³,Süssmeier Frank⁴,Grünewald Sylvia³,Weller Michael¹⁵

Affiliation:

1. Laboratory of Molecular Neuro-Oncology; Department of Neurology; University Hospital and University of Zurich; Zurich Switzerland

2. Laboratory for Molecular Radiobiology; Department of Radiation Oncology; University Hospital Zurich; Zurich Switzerland

3. GTRG Oncology II; Drug Discovery; Bayer Pharma AG; Berlin Germany

4. Medicinal Chemistry; Drug Discovery; Bayer Pharma AG; Wuppertal Germany

5. Center for Neuroscience; University of Zurich; Zurich Switzerland

Funder

Bayer

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.13877/fullpdf

Reference50 articles.

1. How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models;Ahmad;J. Neuropathol. Exp. Neurol.,2014

2. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis;Brunckhorst;Cancer Res.,2010

3. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1;Caine;Eur. J. Clin. Invest.,2003

4. Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas;Chae;Clin. Cancer Res.,2010

5. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas;Cortes-Santiago;Oncotarget,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model;Scientific Reports;2023-11-23

2. Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma;Neuro-Oncology;2023-06-19

3. Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma;Science Translational Medicine;2023-05-24

4. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery;Pharmaceutics;2022-12-24

5. Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3;Cancers;2022-05-21